✦ LIBER ✦

Cancer pharmacogenomics: progress and obstacles toward the goal

✍ Scribed by Masahiko Nishiyama

Book ID: 106284773
Publisher: Springer
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 10
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-004-0462-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HapMap, pharmacogenomics, and the goal o

HapMap, pharmacogenomics, and the goal of personalized prescribing

✍ Kevin M. O’Shaughnessy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Progress Toward the Millennium Developme

Progress Toward the Millennium Development Goals in Africa

✍ David E Sahn; David C Stifel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Assessing Progress Toward the Goals of C

Assessing Progress Toward the Goals of Coastal Management

✍ Olsen, Stephen B. 📂 Article 📅 2002 🏛 Taylor and Francis Group 🌐 English ⚖ 297 KB

Cancer Pharmacogenomics in Children: Res

Cancer Pharmacogenomics in Children: Research Initiatives and Progress to Date

✍ Rassekh, Shahrad Rod; Ross, Colin J. D.; Carleton, Bruce C.; Hayden, Michael R. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 285 KB

Predictive Biomarkers to Anti-VEGF Thera

Predictive Biomarkers to Anti-VEGF Therapy: Progress toward an Elusive Goal

✍ Gyanchandani, R.; Kim, S. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 338 KB

Eyes on the prize: The longitudinal bene

Eyes on the prize: The longitudinal benefits of goal focus on progress toward a weight loss goal

✍ Kyle E. Conlon; Joyce Ehrlinger; Richard P. Eibach; A. William Crescioni; Jessic 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 137 KB